These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1124382)

  • 1. [New aspects of tuberculosis therapy].
    Haegi V
    Schweiz Med Wochenschr; 1975 Feb; 105(8):245-50. PubMed ID: 1124382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
    Nocke-Finck L; Breuer H; Reimers D
    Dtsch Med Wochenschr; 1973 Aug; 98(33):1521-3. PubMed ID: 4580141
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Which treatment for primary tuberculosis?].
    Gallet S; Bellon G
    Pediatrie; 1989; 44(9):699-704. PubMed ID: 2695890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent rifampicin treatment of tuberculosis.
    Riska N; Mattson K
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract]   [Full Text] [Related]  

  • 7. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
    Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
    Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L
    Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 14. An experimental attempt of intensified chemotherapy with rifampicin combined with other drugs.
    Hokama S
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):57-61. PubMed ID: 5317096
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract]   [Full Text] [Related]  

  • 16. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
    Dickinson JM
    Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Pogodaeva NP; Iavorskiĭ KM
    Probl Tuberk; 1994; (6):16-8. PubMed ID: 7708637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.